In the high exposure levels at 270 and 810 ppm, altered cell foci in the livers of both rats and mice, and fibrosis and cirrhosis in the rat liver were observed. Hematoxylin and eosin-stained altered cell foci of rats were recognized as glutathione-S-transferase placental form (GST-P) positive foci, which are preneoplastic lesions of hepatocarcinogenesis. The most sensitive endpoint of CCl 4 -induced toxicity was fatty change with large droplets in rats of both sexes and male mice, and cytoplasmic globules in male mice, as well as increased relative liver weight in male rats. Those endpoints were manifested at 10 ppm and the LOAEL was determined as 10 ppm for the hepatic endpoints in rats and mice. Enhanced cytolytic release of liver transaminases into plasma in rats and mice and its close association with hepatic collapse in mice were observed at medium and high levels of inhalation exposure. Both CCl 4 -induced hematotoxicity and nephrotoxicity were observed in both rats and mice, but those toxicities were manifested at higher exposure concentrations than hepatotoxicity. The LOAEL for the hepatic endpoint and the GST-Pstained altered cell foci provide relevant animal data for reconsidering the occupational exposure limit value of 5 ppm for CCl 4 and strengthen the evidence of CCl 4 -induced hepatocarcinogenicity which is used in its carcinogenicity classification. (J Occup Health 2007; 49: 249-259) 
The Montreal Protocol and its subsequent amendments 1) have established the phase-out by 1996 of production and use of carbon tetrachloride (CCl 4 ). United States' production of CCl 4 peaked at 1,200 million pounds in the early 1970s, then decreased steadily and production of CCl 4 was completely banned as of January 1, 2000 2) . The annual production volume of CCl 4 in Japan remained constant at about 50,000 tons from 1975 to 1993, and then declined rapidly 3) . However, a sizable volume of CCl 4 ranging from 60 to 300 tons/yr was still being imported to Japan in the years following 2000 3) . A nationwide survey in Japan by Ukai et al. 4) showed no use of CCl 4 as an organic solvent in small-and mediumscale industries in 1996, except for testing and research purposes. Kauppinen et al. 5) reported that CCl 4 is one of the most frequently reported exposures among laboratory workers reported to the Finnish Register of Workers Exposed to Carcinogens. Workers are at high risk of exposure to high levels of CCl 4 through inhalation and dermal contact. On the other hand, the general population may also be exposed to low levels of CCl 4 through inhalation from the atmospheric environment 6) and through ingestion of CCl 4 contaminating public water 7) . Occupational CCl 4 poisoning has been characterized by central nervous system depression, and disorders of the liver and kidneys 8, 9) . In experimental toxicology, CCl 4 -induced toxicity and its mechanisms have been extensively investigated by oral administration of CCl 4 to rats and mice (see reviews [9] [10] [11] ), and some of these animal studies have been used to assess health risks to humans from ingestion of CCl 4 -contaminated water and food [12] [13] [14] [15] [16] . However, there have been few inhalation studies [17] [18] [19] on subchronic or chronic CCl 4 toxicity which have adequately delineated dose-response relationships to determine the effective endpoints for health risk assessment of workers exposed to CCl 4 vapor by inhalation. Data of animal toxicity from inhalation exposure to CCl 4 are more relevant for assessing health risks to workers inhaling CCl 4 than those from oral administration, because inhalation is the principal route of entry of CCl 4 into the body, and because the hepatotoxicity resulting from inhalation exposure is reported to be different from that from oral administration of CCl 4 20, 21) . The aim of the present study was to characterize subchronic inhalation toxicity of CCl 4 , using two rodent species of both sexes, with particular emphasis placed on delineation of dose-response relationships to determine the effective endpoints for health risk assessment of workers inhaling CCl 4 . For this purpose, the lowest inhalation concentration of 10 ppm was selected in consideration of the validity of the present occupational exposure limit (OEL) value for CCl 4 22-24) . The OEL value was established as 5 ppm by the American Conference on Governmental Industrial Hygienists (ACGIH) in 1981 22) and by the Japan Society for Occupational Health (JSOH) in 1991 23) . However, the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) revised the maximum workplace concentration (MAK) value 24) from 10 ppm to 0.5 ppm in 2000. The high levels of inhalation exposure to CCl 4 used here were selected to explore any precursor lesions that might develop to tumors after long-term exposure to CCl 4 .
Materials and Methods
The present study was carried out with reference to the Organisation for Economic Co-operation and Development (OECD) Guideline for Testing of Chemicals 413 "Subchronic Inhalation Toxicity: 90-day Study" 25) . The animals were cared for in accordance with the Guide for the Care and Use of Laboratory Animals 26) . The present study was approved by the ethics committee of the Japan Bioassay Research Center.
Chemicals
Analytical-grade CCl 4 (greater than 99.8% pure) was obtained from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Each lot of CCl 4 was analyzed for stability and purity by gas chromatography and infrared spectrometry before and after use. Neither decomposition products nor impurities were found in any lot of CCl 4 . No gas chromatographic peak other than CCl 4 was detected in the inhalation exposure chambers. Polyclonal antibody of glutathione-S-transferase placental form (GST-P) (Anti-GST-P) was obtained from Medical & Biological Laboratories Co., Ltd. (Nagoya, Japan).
Animals
Four-wk-old F344/DuCrj rats and Crj:BDF 1 mice of both sexes were obtained from Charles River Japan, Inc. (Kanagawa, Japan). The animals were quarantined and acclimated for 2 wk, and then divided by stratified randomization into 6 weight-matched groups, each consisting of 10 rats and 10 mice of both sexes. Twelve exposure chambers were installed in a barrier system animal room in which a temperature of 24. [H] for mice) in the inhalation exposure chambers. The 12-h light/dark cycle was automatically controlled. All rats and mice had free access to sterilized commercial pellet diet (CRF-1, Oriental Yeast Co., Ltd., Tokyo, Japan) and sterilized drinking water supplied by an automatic watering system.
Exposure to CCl 4
The animals were exposed to CCl 4 at a target concentration of 10, 30, 90, 270 or 810 ppm for 6 h/d, 5 d/wk and 13 wk. Groups of 10 rats and 10 mice of both sexes were exposed to clean air for 13 wk under the same conditions, and served as respective controls.
The methods for generating airflow containing CCl 4 vapor and supplying the airflow to the inhalation exposure chamber were as described previously 27) . The vapor-air mixture flow was generated by bubbling clean air through CCl 4 liquid in a solvent reservoir. The vapor-air mixture was further diluted with clean air and supplied to the inhalation exposure chambers. Air concentrations of CCl 4 vapor in the exposure chambers were maintained constant throughout the 6-h exposure period with the following accuracy and precision: (mean ± standard deviation) 10.0 ± 0.2 ppm, 30.0 ± 0.3 ppm, 90.4 ± 0.6 ppm, 272.0 ± 2.8 ppm and 811.0 ± 6.5 ppm for the rats; and 10.0 ± 0.1 ppm, 30.0 ± 0.3 ppm, 90.1 ± 1.0 ppm, 271.3 ± 3.5 ppm and 810.3 ± 6.7 ppm for the mice throughout the 13-wk exposure period.
Clinical observations and analysis, and pathological examinations
The animals were observed daily for clinical signs and mortality. Body weight and food consumption were measured once a week. Urinary parameters were measured in the last week of the 13-wk exposure period with Ames Reagent Strips (Multistix for rats and UroLabstix for mice, Bayer Corporation, NY, USA). All animals underwent complete necropsy. Blood was collected for hematology and blood biochemistry under etherization after overnight fasting at the end of the 13-wk exposure period. The blood samples were analyzed with an Automatic Blood Cell Analyzer (Coulter Counter SP, Coulter Electronics Inc., FL, USA) for hematology, and an automatic analyzer (Hitachi 705, Hitachi, Ltd., Ibaraki, Japan) and a flame analyzer (Hitachi 750, Hitachi, Ltd., Ibaraki, Japan) for blood biochemistry. Organs were removed, weighed, and examined for macroscopic lesions at the necropsy. All the animals were examined for histopathology. The tissues were fixed in 10% neutral buffered formalin, and embedded in paraffin. Tissue sections of 5 µm in thickness were prepared, and stained with hematoxylin and eosin (H & E). Additionally, the livers of 810 ppm-exposed and control groups of male rats were sectioned for further examination of hepatic altered cell foci, a preneoplastic lesion, by immunohistochemical staining with anti-GST-P [28] [29] [30] using EnVision+ (EV+, Dako, Copenhagen, Denmark) of the two-layer dextran polymer visualization system 31) .
Data analysis
Body weights, organ weights, and hematological and blood biochemical parameters were analyzed by Dunnett's multiple comparison test or the same multiple comparison test by rank. Two-sided analysis with a pvalue of 0.05 was performed. Pathological examinations and urinary parameters were analyzed by Chi-square test with a p-value of 0.05. Application of the statistics was given in detail in the previous paper 32) . Either a no-observed-adverse-effect-level (NOAEL) or a lowest-observed-adverse-effect-level (LOAEL) was determined according to the WHO definition 33) .
Results

Rat study
Survival, body and organ weights: No death occurred in any of the CCl 4 -exposed rat groups of either sex. There was no CCl 4 -related clinical sign except for soiling of the perigenital and perinasal areas in male and female rats exposed to 270 ppm and above. Terminal body weight was significantly decreased only in the 810 ppmexposed male rats (Table 1) . A significant increase in relative organ weight was observed in the livers of male rats exposed to 10 ppm and above and of female rats exposed to 30 ppm and above. The relative kidney weights of male rats exposed to 10 ppm and above, except 30 ppm, and of female rats exposed to 90 ppm and above were significantly increased. A biologically meaningful increase in the relative kidney weight was judged to have occurred in both male and female rats exposed to 90 ppm and above, because a dose-dependent increase was observed in rats of both sexes exposed to 90 ppm and above, and because the statistically increased relative kidney weight of 10 ppm-exposed male rats was attributed to a marginal decrease in the body weight.
Clinical chemistry: While red blood cell counts were significantly decreased in the 810 ppm-exposed rats of both sexes, hemoglobin and hematocrit were significantly decreased in male and female rats exposed to 90 ppm and above (Table 2) . Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and lactate dehydrogenase (LDH) tended to increase in male rats exposed to 90 ppm and above and in female rats exposed to 30 ppm and above, although the increases in AST and LDH in the 90 ppm-exposed male rats were not statistically significant. Alkaline phosphatase (ALP) was significantly increased in male and female rats exposed to 90 ppm and above. Total bilirubin was significantly increased in male rats exposed to 810 ppm and in female rats exposed to 270 and 810 ppm. Urinary protein was significantly increased in male rats exposed to 270 and 810 ppm and in female rats exposed to 90 ppm and above.
Pathology: The liver surface was granular in 1 female rat exposed to 90 ppm, in 5 male rats and 10 female rats exposed to 270 ppm and all male and female rats exposed to 810 ppm.
Incidences of selected microscopic hepatic lesions in the CCl 4 -exposed rats as well as some of the averaged severities are presented in Table 3 . Fatty change ( Fig.  1) , as characterized by large droplets, which were greater in diameter than the hepatocellular nuclei, was significantly increased in both male and female rats exposed to 30 ppm and above, and its averaged severity was increased in a dose-related manner except for the female groups exposed to 270 and 810 ppm. Notably, the inhalation exposure to 10 ppm induced the fatty change with such large droplets in 2 rats of both sexes. However, fatty change having small droplets was seen in both control and 10 ppm-exposed female groups. The incidence of fibrosis was significantly increased in male rats exposed to 270 and 810 ppm and in female rats exposed to 90 ppm and above. Cirrhosis (Fig. 2 ) occurred in both male and female rats exposed to 270 and 810 ppm, although its incidence in the 270 ppm-exposed male rats was not statistically significant. Either fibrosis or cirrhosis was accompanied by increased mitosis and nuclear enlargement of hepatocytes, proliferation of bile duct and deposition of ceroid-like yellow pigment in the connective tissue area. Altered cell foci (Fig. 3A) , which were characterized by expansile nodules composed of the tinctorially distinguishable hepatocytes from the adjacent parenchyma, were observed in male rats exposed to 270 and 810 ppm, and in female rats exposed to 90 ppm and above, although the incidences in the 270 ppmexposed male rats and in the 90 ppm-exposed female rats were not statistically significant. The altered cell foci were further classified into acidophilic, basophilic or clear cell foci, depending upon the tinctorial characteristics of hepatocyte cytoplasm in the H & E-stained sections. It was found that these H & E-stained altered cell foci seen in the 810 ppm-exposed male rats were also stained positively with the anti-GST-P antibody (Fig. 3B) , whereas there were no GST-P-positive foci in the livers of male controls. The altered cell foci were homogeneously composed of GST-P positive hepatocytes.
Localized glomerulosclerosis, which was characterized by segmental deposition of hyaline material in several glomeruli, was significantly increased in both male and female rats exposed to 810 ppm (Table 3) .
No histopathological change was observed in the respiratory tracts, including the nasal cavity, larynx, trachea or lungs, of any CCl 4 -exposed rat group of either sex.
Mouse study
Survival, body and organ weights: One male mouse each of the control and 10 ppm-exposed groups died of hydronephrosis, but their deaths were not related to the exposure to CCl 4 . No CCl 4 -related clinical sign was found in any of the CCl 4 -exposed mouse groups of either sex. Terminal body weight was significantly decreased only in male mice exposed to 30 ppm and above (Table 4) . A statistically significant increase in relative organ weights occurred in the livers and kidneys of male mice exposed to 30 ppm and above and of female mice exposed to 270 and 810 ppm. However, the statistically significant increase in the relative kidney weight of the 30 ppmexposed male group was attributed to the markedly increased kidney weight of 2 male mice suffering from hydronephrosis. Therefore, a biologically meaningful increase in relative kidney weight was judged to occur in male mice exposed to 90 ppm and above and in female mice exposed to 270 and 810 ppm.
Clinical chemistry: While only the 810 ppm-exposed male mice exhibited significantly decreased hemoglobin, the female mice exposed to 270 and 810 ppm showed a significant decrease in red blood cell counts, hemoglobin and hematocrit, except for the hematocrit value at 270 ppm (Table 5) . ALT was significantly increased in male and female mice exposed to 90 ppm and above. A significant increase in AST occurred only in male mice exposed to 270 and 810 ppm. ALP was significantly increased only in male mice exposed to 30 ppm and above. No significant change in LDH or in the urinary protein, occurred in any CCl 4 -exposed male or female mouse.
Pathology: None of the mice in any of the CCl 4 -exposed groups of either sex had livers with a granular surface.
Incidences and averaged severities of selected microscopic lesions in the livers of CCl 4 -exposed mice are presented in Table 6 . Cytoplasmic globules (Fig. 4) of up to 20 µm in size, palely stained with eosin, were observed in the centrilobular hepatocytes of the CCl 4 -exposed mice. The incidence of cytoplasmic globules was significantly increased in all CCl 4 -exposed male groups and in female mice exposed to 30 ppm and above, and their average severity increased in a dose-related manner. Fatty change (Fig. 4 ) with large droplets was significantly increased in male mice exposed to 10, 30 and 90 ppm and in female mice exposed to 30 ppm, whereas no fatty change with such large droplets occurred in either male or female controls. However, fatty change having small droplets was observed in both control and low-level-exposed mice of both sexes, and neither its incidence nor severity was doserelated. A significantly increased incidence of collapse, which was characterized by the shrunken parenchymal tissue over the centrilobular area, presumably resulting from the necrotic loss of hepatocytes, was observed in both male and female mice exposed to 30 ppm and above, and its averaged severity was increased in a dose-related manner. Hepatic collapse was accompanied by both proliferation of the bile ducts and oval cells and deposition of ceroid-like yellow pigment. Nuclear enlargement of hepatocytes with atypia, often having irregularly shaped nuclei, was significantly increased in male and female mice exposed to 270 and 810 ppm. Neither fibrosis nor cirrhosis occurred in any of the CCl 4 -exposed mice of either sex. Altered cell foci (Fig. 5) were significantly increased in male mice exposed to 270 and 810 ppm. They were also observed in female mice exposed to 270 ppm but their incidence was not statistically significant. The altered cell foci were characterized by a focal area composed of hepatocytes tinctorially distinguishable from adjacent parenchyma, and were further classified into acidophilic, basophilic, clear or mixed cell foci, according to their tinctorial characteristics. No histopathological change was observed in the nasal cavity, larynx, trachea or lungs of any of the CCl 4 -exposed mouse groups of both sexes.
Discussion
The present study shows that repeated inhalation exposure of rats and mice of both sexes to CCl 4 vapor at 10 to 810 ppm for 13 wk induced mild to severe hepatotoxicity including a preneoplastic lesion, as well as renal and hematological toxicities to a less severe extent. However, inhalation exposure of rats and mice of both sexes to CCl 4 vapor did not produce any histopathological change in the respiratory tracts, including the nasal cavity, larynx, trachea and lungs. The present study confirmed the pathological findings of earlier inhalation studies [17] [18] [19] , by demonstrating the increased liver weight, enhanced release of transaminases into plasma and fatty degeneration in rats and mice, fibrosis and cirrhosis in rats, and cytoplasmic globules and collapse in mice. Furthermore, the present study extended these previously reported findings to the histopathologically novel observations that inhalation exposure to high levels of CCl 4 for 13 wk induced the hepatic altered cell foci mirrored by GST-P-positively stained hepatocytes as a preneoplastic lesion [28] [29] [30] , while the low levels of CCl 4 designated 10 ppm for the most sensitive sign as fatty change, cytoplasmic globules and increased liver weight. Both the preneoplastic lesion and the most sensitive sign would be available for health risk assessment of workers exposed to CCl 4 by inhalation.
It is especially noteworthy in the present study that altered cell foci, which are known as a precursor lesion of hepatocellular tumors 34) , were found in male rats exposed to 270 and 810 ppm, in female rats exposed to 90 ppm and above, in male mice exposed to 270 and 810 ppm and in female mice exposed to 270 ppm, and that the altered cell foci of rats were stained positively with anti-GST-P antibody. It has been reported that GST-P is markedly induced in the liver foci and nodules in the early stages of chemical hepatocarcinogenesis, while the content of GST-P is very low in normal liver tissue 35, 36) . GST-P has been reported to be an effective marker enzyme for detection of preneoplastic lesions in chemical hepatocarcinogenesis [28] [29] [30] . Ito et al. 30, 37, 38) also reported that almost all hepatocarcinogens induced GST-P positive foci in the liver, which allowed prediction of hepatocarcinogenicity with high probability. Therefore, it can be concluded from the present result from positive immunochemical staining of the altered cell foci with GST-P that induction of the altered cell foci by 13-wk inhalation exposure to CCl 4 might develop to hepatocellular tumors after long-term inhalation exposure.
Well-known macro-and micro-scopic lesions of fibrosis and cirrhosis were confirmed in rats of both sexes exposed to high levels of CCl 4 at 270 and 810 ppm as well as in the 90 ppm-exposed female rats, whereas those severe signs were not observed in any of the CCl 4 -exposed mice. These results suggest that a difference in occurrence of these severe hepatotoxic signs exists between rats and mice, although any causative factor for the species difference remains to be explored. Enhanced cytolytic release of liver-associated transaminases into plasma, reflecting a necrotic change in hepatocytes, occurred in male rats and mice of both sexes exposed to 90 ppm and above and in female rats exposed to 30 ppm, suggesting that these biochemical alterations were induced at lower exposure concentrations than the fibrotic and cirrhotic changes. Hepatic collapse found in male and female mice exposed to 30 ppm and above might have resulted from hepatocellular necrosis acutely induced by CCl 4 and thus gave a good association with the enhanced cytolytic release of ALT into plasma. The collapse was not observed in any CCl 4 -exposed rat of either sex, and was considered indicative of a necrotic lesion specifically occurring in mice.
The most sensitive signs were found to be the increased liver weight occurring in male rats exposed to 10 ppm, the fatty change with large droplets occurring in male and female rats and male mice exposed to 10 ppm and the cytoplasmic globules occurring in male mice exposed to 10 ppm. Both the fatty change and the cytoplasmic globules were characteristic of excessive lipid accumulation and the appearance of palely eosinophilic materials in the hepatocellular cytoplasm, respectively. Therefore, a LOAEL of 10 ppm can be determined as the hepatic endpoint of the two rodent species on the following basis. First, dose-response relationships were found to hold for these hepatic endpoints except for the fatty change with the large droplets in the exposed mice. Second, both fatty change with large droplets and cytoplasmic globules are thought to morphologically reflect degenerative changes rather than any adaptive change, aside from increased liver weight. The LOAEL value of 10 ppm for CCl 4 on the basis of 6 h/d found in the present study is thought to be lower than the previously reported NOAELs 17, 18) determined by repeated inhalation exposure of experimental animals to CCl 4 vapor, when daily exposure length of time was taken into account. Adams et al. 17) reported that while repeated inhalation exposure of rats to 10 ppm CCl 4 for 7 h/d and 192 d induced both increased liver weight and fatty degeneration in the liver, 5 ppm did not produce any change. Prendergast et al. 18) reported that continuous inhalation exposure of rats to 1 ppm CCl 4 for 24 h/d and 90 d did not produce any specific pathologic change attributable to the exposure, while 10 ppm induced fatty change, fibroblastic proliferation and hepatic cell degeneration and regeneration. Oral administration of CCl 4 to rats and mice by gavage was also reported to induce the same kinds of pathologic and biochemical responses as those found in this inhalation study. Bruckner et al. 12) reported that oral administration of CCl 4 to rats for 12 wk at a dose of 1 mg/kg elicited no apparent adverse effects, whereas 10 mg/kg produced both increased sorbitol dehydrogenase activity and hepatic centrilobular vacuolization. Their data 12) suggested 1 mg/ kg/d as a NOAEL. Condie et al. 13) reported that an oral dose of 12 mg CCl 4 /kg/d by gavage to CD-1 mice for 90 d induced hepatocellular vacuolar change, fatty accumulation and increased serum activities of AST, ALT and LDH, designating a lower dose of 1.2 mg/kg/d as a NOAEL. Hayes et al. 14) reported that oral administration of CCl 4 to mice for 90 d induced fatty change and increased LDH and ALT activities at a daily dose of 12 mg/kg. Their data 14) suggested a LOAEL of 12 mg/kg/d. Therefore, 6-h inhalation exposure of rats and mice to 10 ppm CCl 4 vapor corresponds to a daily CCl 4 uptake of 13 mg/kg and 29 mg/kg body weight, respectively, assuming a minute volume of 561 ml/min/kg body weight for rats 39) and 1,239 ml/min/kg body weight for mice 40) and a lung absorption ratio of 100% for both rats and mice. Therefore, the LOAEL value of 10 ppm for the hepatic endpoint of rats and mice inhaling CCl 4 appears to be higher than the NOAEL and LOAEL values from the oral administration of CCl 4 to rats and mice by gavage. This can be partly attributed to the first-pass effect of CCl 4 entering the liver directly through the gastrointestinal tract by bolus gavage dose, as suggested by Sanzgiri et al. 20, 21) . CCl 4 -induced nephrotoxicity was manifested as increased relative kidney weight in rats and mice, and a significantly increased incidence of localized glomerulosclerosis and increased urinary protein in rats. CCl 4 -induced hematotoxicity occurred as decreases in erythrocyte parameters in rats and mice. Both nephrotoxicity and hematotoxicity were induced at higher exposure concentrations than the CCl 4 -induced hepatotoxicity. Consistently, medical case studies on human CCl 4 poisoning 8, 41, 42) have reported that the liver is a target organ of human CCl 4 poisoning and the kidney impairment and erythrocyte injury often accompany liver damage.
It is interesting to note that the German MAK value of 0.5 ppm for CCl 4 established in 2000 24) is one tenth lower than the current OEL value of 5 ppm recommended by the ACGIH in 1996 22) and the JSOH in 1991 23) . The lowered MAK value of 0.5 ppm which was based on the result of marginal effects of exposure to CCl 4 concentrations of about 1 ml/m 3 in man (reduced hematocrit) was not in conflict with the NOEL of 1 mg/ kg body weight 12) determined in studies with oral administration to the rat. Exposure to CCl 4 concentrations of 0.5 ml/m 3 for 8 h a day would correspond to a daily uptake of 0.5 mg/kg body weight for man 24) . Recommendations of the OEL value of 5 ppm for CCl 4 by ACGIH and JSOH were based on both animal and human studies 22, 23) . The hepatic endpoints of fatty change in rats and mice and cytoplasmic globules in mice employed for the determination of the LOAEL are not adaptive but degenerative in nature. The route of exposure and the daily and weekly exposure regimens employed in this study closely simulate workers' inhalation exposure in the workplace. Assuming an uncertainty factor of 10 for extrapolation of rodent data to humans 43) , one tenth of the present LOAEL value might fall below the current OEL value of 5 ppm, suggesting the need to reconsider the OEL for CCl 4 .
ACGIH classified carcinogenicity of CCl 4 as A2, a suspected human carcinogen, based on the increased liver tumor incidence in mice and hamsters receiving oral administration of CCl 4 , shedding light on a threshold mechanism of carcinogenic action on the basis of both the absent or very weak genotoxicity of CCl 4 and the association with cytotoxicity and regenerative hyperplasia 22) . DFG also assigned CCl 4 to Carcinogen category 4 24) , indicating that genotoxicity plays no or at most a minor part and no significant contribution to human cancer risk is expected provided that the MAK value is observed. Therefore, the present finding of occurrence of the altered cell foci in the liver resulting from the subchronic inhalation exposure of rats and mice to CCl 4 provides cancer-related animal data strengthening the evidence of CCl 4 -induced hepatocarcinogenicity which is used to establish the carcinogenicity classifications by ACGIH, DFG and JSOH, since the GST-P positive foci are known as a preneoplastic lesion that allows prediction of hepatocarcinogenicity with high probability 30, 37, 38) . Further inhalation studies will be urgently needed to confirm hepatocarcinogenicity by 2-yr inhalation exposure of rats and mice of both sexes to CCl 4 vapor.
As stated in the documentations by ACGIH 22) and DFG 24) , involvement of genotoxicity in CCl 4 -induced carcinogenesis was negatively evaluated in the carcinogenic risk assessment of CCl 4 . However, a recent study from our laboratory 44) demonstrated that mutagenicity of CCl 4 was positive in E. coli WP2uvrA/ pKM101 and WP2/pKM101 with and without S9 mix and in S. typhimurium TA98 without S9 mix. Thus, the threshold mechanism based on a genotoxic mode-ofaction hypothesis will have to be re-examined for CCl 4 -induced carcinogenesis.
In conclusion, the present study demonstrated that 13-wk inhalation exposure of rats and mice of both sexes to CCl 4 induced mild to severe hepatotoxicity as well as hemato-and nephro-toxicities to a lesser extent. Fibrosis and cirrhosis were observed in the rats exposed to high levels of CCl 4 , but not in any exposed mice. Altered cell foci occurred in the livers of rats and mice exposed to high levels of CCl 4 . Preneoplastic GST-P positive foci of CCl 4 -exposed rats allowed prediction of CCl 4 -induced hepatocarcinogenicity with high probability. The LOAEL was estimated to be 10 ppm for the hepatic endpoint in both rats and mice.
